Aims: Radiation therapy for pituitary adenomas frequently leads to growth hormone (GH)
deficiency. Whether radiation in acromegaly, due to a GH-secreting pituitary adenoma,
induces a comparable change in GH secretion is not known.
Hypothesis: In the long-term, stimulated and spontaneous GH release cannot be distinguished in
patients irradiated for acromegaly or other pituitary adenomas.
Design/subjects: Ten acromegalic patients and 10 patients with other pituitary adenomas were investigated.
Mean time after radiation was 17 and 18.7 years, respectively. Stimulated GH release
was evaluated by infusion of insulin (Insulin Tolerance Test (ITT)), GHRH, GHRH-arginine
and arginine, and spontaneous GH by 10 minutes blood sampling for 24h. Analyses were
by Cluster and approximate entropy.
Outcomes: No group differences existed in stimulated GH concentrations in any test, and the
maximal GH concentration by ITT was below 3µg/L in all patients, compatible with severe
GH deficiency. Spontaneous GH secretion was similar in both patient groups, including
basal release, pulsatility and regularity. Pulsatile secretion was lost in 2 acromegalic
and 3 non-acromegalic patients. IGF-I was below 2 SD-score in 9 patients in each group.
Conclusion: Irradiation in acromegaly leads to loss of GH responses to various stimuli and diminished
spontaneous release. These outcomes are indistinguishable from those of GH deficiency
associated with other irradiated pituitary disorders.